We hope that you join us at the ILCA 2024 Annual Conference in Toronto!
The ILCA AC 2024 program will include the most relevant topics in the field of liver cancer from bench-based basic and translational research to bedside clinical management for patients with hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCA). Sessions will cover the most recent science and advances in screening, diagnosis, and treatment, including surgery, locoregional therapies, systemic agents, and symptom management for patients with liver cancer.
International multidisciplinary experts will provide in-depth presentations and thought-provoking discussions to enhance knowledge and perspective on these current and very important topics in the field. Sessions will be highly interactive with plenty of room for discussion about open issues and future perspectives for patients with liver cancer. It will be an event-provoking paradigm shift in your clinical practice or research that is not to be missed.
